Olainfarm To Expand In Central and South East Asia

Latvian pharmaceutical company Olainfarm has announced plans to open a representative office in Bangkok during 2010, while also expanding into Central Asian markets. BMI considers Olainfarm's continued push into foreign markets a sound strategy, considering its previous success in this area and limited domestic market potential. In our view, the drugmaker's efforts to focus on high growth markets should allow Olainfarm to meet its target of maintaining turnover growth from

To read the full article, please choose one of the following options: